Chaochun Zou

Prof. Chaochun Zou

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 June 2021 in Genes
Verified
Journal Article
Open access
PDF file
LYLili Yang
Lili Yang
XSXiaoli Shu
Xiaoli Shu
SMShujiong Mao
Shujiong Mao
YWYi Wang
Yi Wang
XDXiaonan Du
Xiaonan Du
CZChaochun Zou
Chaochun Zou
Angelman syndrome (AS) is a rare neurodevelopmental disease that is caused by the loss of function of the maternal copy of ubiquitin–protein ligase E3A (UBE3A) on the chromosome 15q11–13 region. AS is characterized by global developmental delay, severe intellectual disability, lack of speech, happy disposition, ataxia, epilepsy, and distinct behavioral profile. There are four molecular mechanisms of etiology: maternal deletion of chromosome 15q11–q13, paternal uniparental disomy of chromosome 15q11–q13, imprinting defects, and maternally inherited UBE3A mutations. Different genetic types may show different phenotypes in performance, seizure, behavior, sleep, and other aspects. AS caused by maternal deletion of 15q11–13 appears to have worse development, cognitive skills, albinism, ataxia, and more autistic features than those of other genotypes. Children with a UBE3A mutation have less severe phenotypes and a nearly normal development quotient. In this review, we proposed to review genotype–phenotype correlations based on different genotypes. Understanding the pathophysiology of the different genotypes and the genotype–phenotype correlations will offer an opportunity for individualized treatment and genetic counseling. Genotype–phenotype correlations based on larger data should be carried out for identifying new treatment modalities.

1 April 2021 in Cell & Bioscience
Verified
Journal Article
Open access
PDF file
YCYunqi Chao
Yunqi Chao
YJYonghui Jiang
Yonghui Jiang
MZMianling Zhong
Mianling Zhong
KWKaiyan Wei
Kaiyan Wei
CHChenxi Hu
Chenxi Hu
CZChaochun Zou
Chaochun Zou
Alternative splicing (AS) regulates gene expression patterns at the post-transcriptional level and generates a striking expansion of coding capacities of genomes and cellular protein diversity. RNA splicing could undergo modulation and close interaction with genetic and epigenetic machinery. Notably, during the adipogenesis processes of white, brown and beige adipocytes, AS tightly interplays with the differentiation gene program networks. Here, we integrate the available findings on specific splicing events and distinct functions of different splicing regulators as examples to highlight the directive biological contribution of AS mechanism in adipogenesis and adipocyte biology. Furthermore, accumulating evidence has suggested that mutations and/or altered expression in splicing regulators and aberrant splicing alterations in the obesity-associated genes are often linked to humans’ diet-induced obesity and metabolic dysregulation phenotypes. Therefore, significant attempts have been finally made to overview novel detailed discussion on the prospects of splicing machinery with obesity and metabolic disorders to supply featured potential management mechanisms in clinical applicability for obesity treatment strategies.

1 June 2018 in European Journal of Pharmacology
Verified
Journal Article
Closed access
ZQZhou Qing
Zhou Qing
WXWu Xiao-Hui
Wu Xiao-Hui
WXWu Xi-Mei
Wu Xi-Mei
CZChaochun Zou
Chaochun Zou

21 January 2020 in Orphanet Journal of Rare Diseases
Verified
Journal Article
Open access
PDF file
LYLili Yang
Lili Yang
QZQiong Zhou
Qiong Zhou
BMBo Ma
Bo Ma
SMShujiong Mao
Shujiong Mao
YDYanli Dai
Yanli Dai
CZChaochun Zou
Chaochun Zou
Background: Prader-Willi syndrome (PWS) is a rare and complex genetic disorder caused by lacking expression of imprinted genes on the paternally derived chromosome 15q11-q13 region. This study aimed to characterize the perinatal features of 134 Chinese individuals with PWS. Methods: This study included the patients of a PWS registry in China. Anonymous data of 134 patients were abstracted. Perinatal and neonatal presentations were analyzed, and compared between the two PWS genetic subtypes. We also compared the perinatal features of PWS patients with the general population and other previous reported large cohorts from France, UK and USA. Results: This study included 134 patients with PWS (115 patients with 15q11-q13 deletion and 19 with maternal uniparental disomy). Higher mean maternal age was found in this cohort (30.5 vs. 26.7), particularly in the maternal uniparental disomy (UPD) group (36.0 vs. 26.7) comparing with the general population. 88.6% of mothers reported a decrease of fetal movements. 42.5 and 18.7% of mothers had polyhydramnios and oligohydramnios during pregnancy, respectively. 82.8% of the patients were born by caesarean section. 32.1% of neonates had birth asphyxia, 98.5% had hypotonia and 97.8% had weak cry or even no cry at neonatal period. Feeding difficulty existed in 99.3% of the infants, 94.8% of whom had failure to thrive. 69.4% of the infants ever used feeding tube during hospitalization, however, 97.8% of them discontinued tube feeding after discharge. Maternal age and pre-pregnancy weight were significantly higher in the UPD group (both P < 0.05). Conclusions: Differential diagnosis of PWS should be highlighted if infants having following perinatal factors including polyhydramnios, decreased intrauterine fetal movements, caesarean section, low birth weight, feeding difficulty, hypotonia and failure to thrive. Higher maternal age may be a risk factor of PWS, especially for UPD. Further studies are needed for elucidating the mechanism of PWS.

10 October 2024 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
YQYiFang Qin
YiFang Qin
CHChenXi Hu
ChenXi Hu
JJJiaLe Jin
JiaLe Jin
YCYunQi Chao
YunQi Chao
DWDongYu Wang
DongYu Wang
CZChaochun Zou
Chaochun Zou

20 September 2023 in Journal of Endocrinological Investigation
Verified
Journal Article
Closed access
PDF file
MZM.-L. Zhong
M.-L. Zhong
YCY.-Q. Cai
Y.-Q. Cai
YTY.-F. Tang
Y.-F. Tang
YDY.-L. Dai
Y.-L. Dai
YJY.-H. Jiang
Y.-H. Jiang
CZChaochun Zou
Chaochun Zou